Ralf Gold

1970–2026 年に発表

293
論文数
36,913
被引用数
103
h 指数
275
i10 指数

被引用数

Ralf Gold の年別被引用数1971 年: 被引用 1 件1972 年: 被引用 1 件1973 年: 被引用 2 件1976 年: 被引用 2 件1977 年: 被引用 2 件1978 年: 被引用 1 件1979 年: 被引用 1 件1981 年: 被引用 1 件1985 年: 被引用 2 件1986 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 13 件1995 年: 被引用 53 件1996 年: 被引用 51 件1997 年: 被引用 76 件1998 年: 被引用 79 件1999 年: 被引用 76 件2000 年: 被引用 64 件2001 年: 被引用 76 件2002 年: 被引用 74 件2003 年: 被引用 75 件2004 年: 被引用 58 件2005 年: 被引用 68 件2006 年: 被引用 101 件2007 年: 被引用 109 件2008 年: 被引用 117 件2009 年: 被引用 156 件2010 年: 被引用 231 件2011 年: 被引用 228 件2012 年: 被引用 218 件2013 年: 被引用 332 件2014 年: 被引用 272 件2015 年: 被引用 379 件2016 年: 被引用 295 件2017 年: 被引用 280 件2018 年: 被引用 342 件2019 年: 被引用 1,139 件2020 年: 被引用 1,439 件2021 年: 被引用 1,497 件2022 年: 被引用 1,325 件2023 年: 被引用 969 件2024 年: 被引用 1,570 件2025 年: 被引用 876 件2026 年: 被引用 32 件1974〜1975 年は被引用が無いため表示していません1980 年は被引用が無いため表示していません1982〜1984 年は被引用が無いため表示していません1987〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,359 件、この内訳の 20.4%ドイツ: 引用元論文 1,911 件、この内訳の 11.6%中国: 引用元論文 1,390 件、この内訳の 8.4%イギリス: 引用元論文 1,061 件、この内訳の 6.4%イタリア: 引用元論文 966 件、この内訳の 5.9%カナダ: 引用元論文 635 件、この内訳の 3.9%フランス: 引用元論文 546 件、この内訳の 3.3%スイス: 引用元論文 531 件、この内訳の 3.2%スペイン: 引用元論文 524 件、この内訳の 3.2%オーストラリア: 引用元論文 457 件、この内訳の 2.8%オランダ: 引用元論文 457 件、この内訳の 2.8%日本: 引用元論文 384 件、この内訳の 2.3%
0%20.4%その他 25.8%

分野

  • Medicine51.7%
  • Biochemistry, Genetics and Molecular Biology20.5%
  • Neuroscience16.1%
  • Immunology and Microbiology8.4%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.6%
  • その他2%

トピック

  • Multiple Sclerosis Research Studies9.4%
  • Neuroinflammation and Neurodegeneration Mechanisms6.2%
  • Peripheral Neuropathies and Disorders4.1%
  • Gut microbiota and health2.5%
  • Neurogenesis and neuroplasticity mechanisms1.9%
  • Immune cells in cancer1.9%
  • その他74%

共著者

全論文

検索で開く
  1. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

    著者: , , , , , , , , , , , , , , , , , , - Nature 2019 被引用: 1,375

  2. Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carsten Lukas, Sören Gatermann, Markus Scholz, H. Przuntek, Marco Prinz, Sofia K. Forslund, Konstanze F. Winklhofer, Dominik N. Müller, Ralf A. Linker, Ralf Gold, Aiden Haghikia - Cell 2020 被引用: 647

  3. Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine

    著者: , , , , , , , , , , , , , , , , , , , , , - Immunity 2015 被引用: 920

  4. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aiden Haghikia, Ulf Landmesser - European Heart Journal 2021 被引用: 355

  5. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mihaela Bejinariu, Florian Then Bergh, Arnfin Bergmann, Evanthia Bernitsas, Achim Berthele, Virender Bhan, Felix Bischof, Randall J. Bjork, Gregg Blevins, Matthias Boehringer, Thomas Boerner, Robert Bonek, James D. Bowen, Allen C. Bowling, Alexey Boyко, Cavit Boz, Vera Bracknies, Stefan Braune, Vincenzo Brescia Morra, Bruno Brochet, Waldemar Brola, Paul Brownstone, M Brozman, Donald Brunet, Ioan Buraga, Margaret Burnett, Mathias Buttmann, Helmut Butzkueven, Jonathan Cahill, Jonathan Calkwood, William Camu, Mark Cascione, G. Castelnovo, Diego Centonze, João Cerqueira, Andrew Chan, Andrea Cimprichová, Stanley Cohan, Giancarlo Comi, Jill Ker Conway, Joanna A. Cooper, John R. Corboy, Jorge Correale, Brian Costell, David A. Cottrell, Patricia K. Coyle, Matthew Craner, Liying Cui, Luı́s Cunha, Anna Członkowska, Ana Silva, Joao de, de Sèze, Marc Debouverie, Jan Debruyne, D. Decoo, G. Defer, Tobias Derfuß, Norma Deri, Bhupesh Dihenia, Péter Diószeghy, Vladimír Donáth, Bénédicte Dubois, Martin Duddy, Pierre Duquette, Gilles Edan, Hüsnü Efendi, Stanton B. Elias, Peter Emrich, Bonaventura Casanova Estruch ほか 228 名 - The Lancet 2018 被引用: 925

  6. Anti-CD19 CAR T cells for refractory myasthenia gravis

    著者: , , , , , , , , , , - The Lancet Neurology 2023 被引用: 149

  7. Progressive multiple sclerosis: from pathophysiology to therapeutic strategies

    著者: , , , - Nature Reviews Drug Discovery 2019 被引用: 457

  8. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    著者: , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 1,703

  9. Advancements and challenges in CAR T cell therapy in autoimmune diseases

    著者: , , , , , , , , , , , , , - Nature Reviews Rheumatology 2024 被引用: 209

  10. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

    著者: , , , , , , , , , , , , , , , , , - Brain 2011 被引用: 1,168

  11. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Multiple Sclerosis Journal 2018 被引用: 705

  12. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding‐Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp, for the ‘Multiple Sclerosis Therapy Consensus Group’ (MSTCG) - Therapeutic Advances in Neurological Disorders 2021 被引用: 191

  13. Sex and gender issues in multiple sclerosis

    著者: , , - Therapeutic Advances in Neurological Disorders 2013 被引用: 524

  14. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefanie Behnke, Stefan Bittner, Franziska Buetow, Mathias Buttmann, Ankelien Duchow, Daniel Engels, Thorleif Etgen, Katinka Fischer, Benedikt Frank, Anna Gahlen, Achim Gass, Johannes Gehring, Christian Geis, Ralf Gold, Yasemin Göreci, Jonas Graf, Sergiu Groppa, Matthias Grothe, Julia Gutbrod, Kersten Guthke, Axel Haarmann, Maria Hastermann, Bernhard Hemmer, Mariella Herfurth, Marina Herwerth, Frank Hoffmann, Olaf Hoffmann, Martin W. Hümmert, Leila Husseini, Jutta Junghans, Matthias Kaste, Peter Kern, Karsten Kern, Pawel Kermer, Christoph Kleinschnitz, Wolfgang Köhler, Kimberly Körbel, Markus C. Kowarik, Markus Kraemer, Julian Reza Kretschmer, Natalia Kurka, Theodoros Ladopoulus, Ann-Sophie Lauenstein, Sarah Laurent, De-Hyung Lee, Dominik Lehrieder, Frank Leypoldt, Martin Liebetrau, Ralf A. Linker, Gero Lindenblatt, Lisa Lohmann, Felix Lüssi, Peter Luedemann, Michelle Maiworm, Martin Marziniak, Christoph Mayer, Stefanie Meister, Mathias Mering, Imke Metz, Sven G. Meuth, Jasmin Naumann, Oliver Neuhaus, Tradite Neziraj, Moritz Niederschweiberer, Sabine Niehaus, Carolin Otto, Florence Pache, Thivya Pakeerathan, Sarah Passoke, Marc Pawlitzki ほか 40 名 - Journal of Neurology 2023 被引用: 232

  15. Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis

    著者: , , , , , , , , , , , - Annals of the Rheumatic Diseases 2024 被引用: 64

  16. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caspar Seitz, Silke Tonner, Christian Urbanek, Simone Zittel, Robert Markewitz, Mirjam Korporal‐Kuhnke, Thomas Schmitter, Carsten Finke, Norbert Brüggemann, Corinna Bien, Ingo Kleiter, Ralf Gold, Klaus-Peter Wandinger, Gregor Kuhlenbäumer, Frank Leypoldt, Ilya Ayzenberg, Frank Leypoldt, Nico Melzer, Kristin Stefanie Melzer, Christian Geis, Ilya Ayzenberg, Andreas van Baalen, Annette Baumgärtner, Robert L. Berger, Franz Blaes, Astrid Blaschek, Kathrin Doppler, Friedrich Ebinger, Dominique Endres, Jürgen Faiss, Alexander Finke, Carsten Finke, Andre Dik, Paul Friedemann, Manuel A. Friese, Anna Gorsler, Catharina C. Groß, Robert Handreka, Martin Häusler, Valentin Held, Frank Hoffmann, Ulrich Hofstadt-van Oy, Christoph Kellinghaus, Andrea Kraft, Markus Krämer, Christos Krogias, Peter Körtvélyessy, Tanja Kümpfel, Jan Lewerenz, Andeas Linsa, Til Menge, Wolfgang Heide, Joachim Havla, Michael P. Malter, Sven G. Meuth, Constanze Mönig, Marie‐Luise Mono, Michael Nagel, Jost Obrocki, Felix von Poderwils, Josef Priller, Gernot Reimann, Marius Ringelstein, Kevin Rostásy, G Seidel, Oliver Stammel, Muriel Stoppe, Claudia Sommer, Kurt‐Wolfram Sühs, Max Kaufmann ほか 100 名 - Brain 2022 被引用: 117

  17. Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells

    著者: , , , , , , , , , , - Neuron 2024 被引用: 69

  18. Association of obesity with disease outcome in multiple sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2022 被引用: 86

  19. DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisabeth Gulowsen Celius, Helle Bach Søndergaard, Jesper Tegnér, Hanne F. Harbo, Annette Oturai, Sigurgeir Ólafsson, Hannes P. Eggertsson, Bjarni V. Halldórsson, Haukur Hjaltason, Elías Ólafsson, Ingileif Jónsdóttir, Kāri Stefánsson, Tomas Olsson, Fredrik Piehl, Tomas J. Ekström, Ingrid Kockum, Andrew P. Feinberg, Maja Jagodic - Nature Communications 2018 被引用: 212

  20. Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frauke Zipp - EBioMedicine 2020 被引用: 131

  21. Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity via Effects on Th17 Responses

    著者: , , , , , , , , - Frontiers in Immunology 2021 被引用: 57

  22. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG–Associated Disease and Neuromyelitis Optica Spectrum Disorders

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Axel Haarmann, Sven Jarius, Brigitte Wildemann, Matthias Grothe, Nadja Siebert, Klemens Ruprecht, Friedemann Paul, Nicolas Collongues, Romain Marignier, Michael Levy, Michael Karenfort, Michael Deppe, Philipp Albrecht, Kerstin Hellwig, Ralf Gold, Hans‐Peter Hartung, Sven G. Meuth, Ingo Kleiter, Orhan Aktaş, on behalf of the Neuromyelitis Optica Study Group (NEMOS) - Neurology Neuroimmunology & Neuroinflammation 2021 被引用: 147

  23. Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis

    著者: , , , , , , , , , , , - Journal of Neurology 2021 被引用: 97

  24. Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome

    著者: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2024 被引用: 71